Salimi A, Shabani M, Shahsavar S, Naserian A, Khezri S, Karroubian H
J Mol Histol. 2025; 56(2):104.
PMID: 40063258
DOI: 10.1007/s10735-025-10386-7.
Fu J, Liu X, Zhou Y, Zhao S, Zeng L, Pan Y
Radiat Oncol. 2025; 20(1):20.
PMID: 39920834
PMC: 11806759.
DOI: 10.1186/s13014-025-02596-w.
Russo R, Ryffel B
Cells. 2025; 13(24).
PMID: 39768150
PMC: 11674266.
DOI: 10.3390/cells13242058.
Chauhan P, Bhardwaj N, Rajaura S, Chandra H, Singh A, Babu R
Toxicol Rep. 2024; 13:101777.
PMID: 39506978
PMC: 11539143.
DOI: 10.1016/j.toxrep.2024.101777.
Ma Z, Qiu L, Sun J, Wu Z, Liang S, Zhao Y
BMC Pulm Med. 2024; 24(1):457.
PMID: 39285370
PMC: 11406766.
DOI: 10.1186/s12890-024-03268-3.
Inhibiting Invariant Natural Killer T-Cell Activation: A Promising Strategy against Pulmonary Fibrosis.
Yasuma T, Fujimoto H, DAlessandro-Gabazza C, Gabazza E, Hataji O, Kobayashi T
Am J Respir Crit Care Med. 2024; 210(10):1278.
PMID: 39270214
PMC: 11568448.
DOI: 10.1164/rccm.202408-1513LE.
Dihydroquercetin-Loaded Liposomes Change Fibrous Tissue Distribution in the Bleomycin-Induced Fibrosis Model.
Ivanov E, Akhmetshina M, Gizatulina A, Gulyaev M, Pavlova O, Pirogov Y
Acta Naturae. 2024; 16(2):40-49.
PMID: 39188264
PMC: 11345094.
DOI: 10.32607/actanaturae.27440.
YAP1 inhibits the senescence of alveolar epithelial cells by targeting Prdx3 to alleviate pulmonary fibrosis.
Su W, Guo Y, Wang Q, Ma L, Zhang Q, Zhang Y
Exp Mol Med. 2024; 56(7):1643-1654.
PMID: 38945958
PMC: 11297023.
DOI: 10.1038/s12276-024-01277-0.
Bortezomib restrains M2 polarization and reduces CXCL16-associated CXCR6CD4 T cell chemotaxis in bleomycin-induced pulmonary fibrosis.
Zhou T, Lin L, Zhan Y, Zhang Z, Jiang Y, Wu M
Mol Med. 2024; 30(1):70.
PMID: 38789926
PMC: 11127379.
DOI: 10.1186/s10020-024-00836-5.
A mouse model of progressive lung fibrosis with cutaneous involvement induced by a combination of oropharyngeal and osmotic minipump bleomycin delivery.
Grandi A, Ferrini E, Zoboli M, Buseghin D, Pennati F, Khalajzeyqami Z
Am J Physiol Lung Cell Mol Physiol. 2024; 326(6):L736-L753.
PMID: 38651940
PMC: 11381007.
DOI: 10.1152/ajplung.00408.2023.
Unlocking the Future: Pluripotent Stem Cell-Based Lung Repair.
Goecke T, Ius F, Ruhparwar A, Martin U
Cells. 2024; 13(7.
PMID: 38607074
PMC: 11012168.
DOI: 10.3390/cells13070635.
Lung regeneration: diverse cell types and the therapeutic potential.
Chen Y, Li Z, Ji G, Wang S, Mo C, Ding B
MedComm (2020). 2024; 5(2):e494.
PMID: 38405059
PMC: 10885188.
DOI: 10.1002/mco2.494.
Advancing the Boundaries of Immunotherapy in Lung Adenocarcinoma with Idiopathic Pulmonary Fibrosis by a Biomimetic Proteinoid Enabling Selective Endocytosis.
Jiang A, Zheng X, Yan S, Yan J, Yao Y, He W
ACS Nano. 2024; .
PMID: 38319028
PMC: 10883119.
DOI: 10.1021/acsnano.3c09852.
Inhibitor of PD-1/PD-L1: a new approach may be beneficial for the treatment of idiopathic pulmonary fibrosis.
Tan J, Xue Q, Hu X, Yang J
J Transl Med. 2024; 22(1):95.
PMID: 38263193
PMC: 10804569.
DOI: 10.1186/s12967-024-04884-7.
Animal models of acute exacerbation of pulmonary fibrosis.
Ye X, Zhang M, Gu H, Liu M, Zhao Y, Shi Y
Respir Res. 2023; 24(1):296.
PMID: 38007420
PMC: 10675932.
DOI: 10.1186/s12931-023-02595-z.
Protective effects and mechanism of curcumin in animal models of pulmonary fibrosis: a preclinical systematic review and meta-analysis.
Hanyu F, Zheng H, Jiaqi W, Tairan D, Yiyuanzi Z, Qiwen Y
Front Pharmacol. 2023; 14:1258885.
PMID: 37900163
PMC: 10613035.
DOI: 10.3389/fphar.2023.1258885.
GREM1 signaling in cancer: tumor promotor and suppressor?.
Gao Z, Houthuijzen J, Ten Dijke P, Brazil D
J Cell Commun Signal. 2023; 17(4):1517-1526.
PMID: 37615860
PMC: 10713512.
DOI: 10.1007/s12079-023-00777-4.
Identifying oxidative stress-related biomarkers in idiopathic pulmonary fibrosis in the context of predictive, preventive, and personalized medicine using integrative omics approaches and machine-learning strategies.
Yang F, Wendusubilige , Kong J, Zong Y, Wang M, Jing C
EPMA J. 2023; 14(3):417-442.
PMID: 37605652
PMC: 10439879.
DOI: 10.1007/s13167-023-00334-4.
Bezafibrate reduces the damage, activation and mechanical properties of lung fibroblast cells induced by hydrogen peroxide.
Reghelin C, Bastos M, de Souza Basso B, Costa B, Lima K, Cruz de Sousa A
Naunyn Schmiedebergs Arch Pharmacol. 2023; 396(12):3857-3866.
PMID: 37358795
DOI: 10.1007/s00210-023-02595-2.
PRDX1 negatively regulates bleomycin-induced pulmonary fibrosis via inhibiting the epithelial-mesenchymal transition and lung fibroblast proliferation in vitro and in vivo.
Sun H, Ren C, Lee D, Wang W, Guo X, Hao Y
Cell Mol Biol Lett. 2023; 28(1):48.
PMID: 37268886
PMC: 10236698.
DOI: 10.1186/s11658-023-00460-x.